Bovalto Ibraxion

RSS

Withdrawn

This medicine's authorisation has been withdrawn

infectious bovine rhinotracheitis vaccine (inactivated)
MedicineVeterinaryWithdrawn

Lithuanian is available via eTranslation, the European Commission's machine translation service.

Translate to Lithuanian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Bovalto Ibraxion has been withdrawn at the request of the marketing authorisation holder.

български (BG) (273.86 KB - PDF)

Rodyti

español (ES) (211.53 KB - PDF)

Rodyti

čeština (CS) (261.66 KB - PDF)

Rodyti

dansk (DA) (213.32 KB - PDF)

Rodyti

Deutsch (DE) (220.08 KB - PDF)

Rodyti

eesti (ET) (204.87 KB - PDF)

Rodyti

ελληνικά (EL) (286.33 KB - PDF)

Rodyti

français (FR) (212.65 KB - PDF)

Rodyti

hrvatski (HR) (231.45 KB - PDF)

Rodyti

italiano (IT) (209.38 KB - PDF)

Rodyti

latviešu (LV) (244.51 KB - PDF)

Rodyti

lietuvių (LT) (233 KB - PDF)

Rodyti

magyar (HU) (249.94 KB - PDF)

Rodyti

Malti (MT) (258.21 KB - PDF)

Rodyti

Nederlands (NL) (211.02 KB - PDF)

Rodyti

polski (PL) (256.51 KB - PDF)

Rodyti

português (PT) (211.11 KB - PDF)

Rodyti

română (RO) (235.21 KB - PDF)

Rodyti

slovenčina (SK) (258.12 KB - PDF)

Rodyti

slovenščina (SL) (244.33 KB - PDF)

Rodyti

suomi (FI) (209.31 KB - PDF)

Rodyti

svenska (SV) (209.74 KB - PDF)

Rodyti

Product information

български (BG) (705.71 KB - PDF)

Rodyti

español (ES) (674.36 KB - PDF)

Rodyti

čeština (CS) (969.79 KB - PDF)

Rodyti

dansk (DA) (624.29 KB - PDF)

Rodyti

Deutsch (DE) (661.81 KB - PDF)

Rodyti

eesti (ET) (692.55 KB - PDF)

Rodyti

ελληνικά (EL) (1.19 MB - PDF)

Rodyti

français (FR) (671.79 KB - PDF)

Rodyti

hrvatski (HR) (767.57 KB - PDF)

Rodyti

italiano (IT) (679.81 KB - PDF)

Rodyti

latviešu (LV) (999.57 KB - PDF)

Rodyti

lietuvių (LT) (791.74 KB - PDF)

Rodyti

magyar (HU) (981.94 KB - PDF)

Rodyti

Malti (MT) (1007.77 KB - PDF)

Rodyti

Nederlands (NL) (671.31 KB - PDF)

Rodyti

polski (PL) (993.05 KB - PDF)

Rodyti

português (PT) (664.06 KB - PDF)

Rodyti

română (RO) (792.26 KB - PDF)

Rodyti

slovenčina (SK) (995.67 KB - PDF)

Rodyti

slovenščina (SL) (960.57 KB - PDF)

Rodyti

suomi (FI) (678.92 KB - PDF)

Rodyti

svenska (SV) (676.34 KB - PDF)

Rodyti

Íslenska (IS) (680.52 KB - PDF)

Rodyti

norsk (NO) (684.14 KB - PDF)

Rodyti
Latest procedure affecting product information:IAIN/0016
10/08/2016

български (BG) (333.69 KB - PDF)

Rodyti

español (ES) (172.7 KB - PDF)

Rodyti

čeština (CS) (205.62 KB - PDF)

Rodyti

dansk (DA) (172.68 KB - PDF)

Rodyti

Deutsch (DE) (173.21 KB - PDF)

Rodyti

eesti (ET) (168.31 KB - PDF)

Rodyti

ελληνικά (EL) (215.76 KB - PDF)

Rodyti

français (FR) (171.23 KB - PDF)

Rodyti

hrvatski (HR) (192.67 KB - PDF)

Rodyti

italiano (IT) (168.65 KB - PDF)

Rodyti

latviešu (LV) (209.34 KB - PDF)

Rodyti

lietuvių (LT) (200.78 KB - PDF)

Rodyti

magyar (HU) (191.94 KB - PDF)

Rodyti

Malti (MT) (214.75 KB - PDF)

Rodyti

Nederlands (NL) (170.59 KB - PDF)

Rodyti

polski (PL) (207.14 KB - PDF)

Rodyti

português (PT) (172.47 KB - PDF)

Rodyti

română (RO) (195.44 KB - PDF)

Rodyti

slovenčina (SK) (209.19 KB - PDF)

Rodyti

slovenščina (SL) (240.02 KB - PDF)

Rodyti

suomi (FI) (166.83 KB - PDF)

Rodyti

svenska (SV) (172.67 KB - PDF)

Rodyti

Íslenska (IS) (170.24 KB - PDF)

Rodyti

norsk (NO) (168.61 KB - PDF)

Rodyti

Product details

Name of medicine
Bovalto Ibraxion
Active substance
inactivated IBR virus
International non-proprietary name (INN) or common name
infectious bovine rhinotracheitis vaccine (inactivated)
Species
Cattle
Anatomical therapeutic chemical veterinary (ATCvet) code
QI02AA03

Pharmacotherapeutic group

Immunologicals for Bovidae

Therapeutic indication

Active immunisation of cattle to reduce the clinical signs of infectious bovine rhinotracheitis (IBR) and field virus excretion.
The onset of immunity is 14 days and the duration of immunity is 6 months.

Authorisation details

EMA product number
EMEA/V/C/000051
Marketing authorisation holder
Merial

29 Avenue Tony Garnier
69007 Lyon
France

Marketing authorisation issued
09/03/2000
Revision
10

Assessment history

This page was last updated on

Share this page